|
Test samples | Cytotoxicity test | Aberrations/100 cells | Number of cells with aberrations | % of cells with aberrations |
Relative cell growth (RCG) | Relative mitotic index (RMI) | Chromatid type | Chromosome type | Others |
RCG% | Cytotoxicity% | RMI% | Cytotoxicity% | Gap+ | Gap− | Gap+ | Gap− | Gap+ | Gap− | Gap− |
|
Without S9 activation | | | | | | | | | | | | |
Negative control (DMSO, 0.1%) | | | | | | | | | | | | |
Parallel Slide 1 | 100 | 0 | 100 | 0 | 2 | 1 | 0 | 0 | 0 | 1 | 1 | 1.0 |
Parallel Slide 2 | 0 | 1 | 0 | 1 | 0 | 0 | 2 | 2.0 |
Mean | 1.0 | 1.0 | 0.0 | 0.5 | 0.0 | 0.5 | 1.5 | 1.5 |
Test item | | | | | | | | | | | | |
Parallel Slide 1 (5 μg/mL) | 95 | 5 | 72 | 28 | 1 | 2 | 0 | 0 | 0 | 1 | 2 | 2.0 |
Parallel Slide 2 (5 μg/mL) | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 1.0 |
Mean (5 μg/mL) | 0.5 | 1.5 | 0.0 | 0.0 | 0.0 | 0.5 | 1.5 | 1.5 |
Parallel Slide 1 (10 μg/mL) | 82 | 18 | 70 | 30 | 0 | 4 | 0 | 1 | 0 | 0 | 3 | 3.0 |
Parallel Slide 2 (10 μg/mL) | 2 | 5 | 0 | 1 | 0 | 2 | 3 | 3.0 |
Mean (10 μg/mL) | 1.0 | 4.5 | 0.0 | 1.0 | 0.0 | 1.0 | 3.0 | 3.0 |
Parallel Slide 1 (15 μg/mL) | 66 | 34 | 56 | 44 | 0 | 11 | 0 | 3 | 0 | 0 | 6 | 6.0 |
Parallel Slide 2 (15 μg/mL) | 4 | 9 | 0 | 1 | 0 | 3 | 3 | 3.0 |
Mean (15 μg/mL) | 2.0 | 10.0 | 0.0 | 2.0 | 0.0 | 1.5 | 4.5 | 4.5 |
Positive control (mitomycin C) | | | | | | | | | | | | |
Parallel Slide 1 (0.4 μg/mL) | 40 | 60 | 84 | 16 | 1 | 15 | 0 | 5 | 1 | 1 | 19 | 19.0 |
Parallel Slide 2 (0.4 μg/mL) | 0 | 18 | 0 | 0 | 0 | 0 | 18 | 18.0 |
Mean (0.4 μg/mL) | 0.5 | 16.5 | 0.0 | 2.5 | 0.5 | 0.5 | 18.5 | 18.5 |
Parallel Slide 1 (0.8 μg/mL) | 24 | 76 | 53 | 47 | 3 | 28 | 0 | 10 | 1 | 3 | 23 | 23.0 |
Parallel Slide 2 (0.8 μg/mL) | 2 | 39 | 0 | 2 | 1 | 2 | 34 | 34.0 |
Mean (0.8 μg/mL) | 2.5 | 33.5 | 0.0 | 6.0 | 1.0 | 2.5 | 28.5 | 28.5 |
With S9 activation | | | | | | | | | | | | |
Negative control (DMSO, 0.1%) | | | | | | | | | | | | |
Parallel Slide 1 | 100 | 0 | 100 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 2 | 2.0 |
Parallel Slide 2 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 1.0 |
Mean | 0.5 | 1.5 | 0.0 | 0.0 | 0.0 | 0.5 | 1.5 | 1.5 |
Test item | | | | | | | | | | | | |
Parallel Slide 1 (5 μg/mL) | 86 | 14 | 70 | 30 | 0 | 2 | 0 | 0 | 0 | 0 | 1 | 1.0 |
Parallel Slide 2 (5 μg/mL) | 4 | 1 | 0 | 1 | 0 | 1 | 1 | 1.0 |
Mean (5 μg/mL) | 2.0 | 1.5 | 0.0 | 0.5 | 0.0 | 0.5 | 1.0 | 1.0 |
Parallel Slide 1 (10 μg/mL) | 69 | 31 | 59 | 41 | 5 | 0 | 0 | 0 | 0 | 1 | 0 | 0.0 |
Parallel Slide 2 (10 μg/mL) | 2 | 3 | 0 | 1 | 0 | 2 | 3 | 3.0 |
Mean (10 μg/mL) | 3.5 | 1.5 | 0.0 | 0.5 | 0.0 | 1.5 | 1.5 | 1.5 |
Parallel Slide 1 (15 μg/mL) | 53 | 47 | 56 | 44 | 1 | 8 | 0 | 1 | 0 | 1 | 7 | 7.0 |
Parallel Slide 2 (15 μg/mL) | 4 | 10 | 0 | 5 | 0 | 3 | 5 | 5.0 |
Mean (15 μg/mL) | 2.5 | 9.0 | 0.0 | 3.0 | 0.0 | 2.0 | 6.0 | 6.0 |
Positive control (cyclophosphamide) | | | | | | | | | | | | |
Parallel Slide 1 (7.5 μg/mL) | 44 | 56 | 28 | 72 | 2 | 38 | 0 | 8 | 1 | 2 | 33 | 33.0 |
Parallel Slide 2 (7.5 μg/mL) | 1 | 23 | 0 | 6 | 2 | 1 | 19 | 19.0 |
Mean (7.5 μg/mL) | 1.5 | 30.5 | 0.0 | 7.0 | 1.5 | 1.5 | 26.0 | 26.0 |
Parallel Slide 1 (15 μg/mL) | 39 | 61 | 21 | 79 | 4 | 52 | 0 | 11 | 2 | 4 | 50 | 50.0 |
Parallel Slide 2 (15 μg/mL) | 0 | 35 | 0 | 8 | 1 | 0 | 32 | 32.0 |
Mean (15 μg/mL) | 2.0 | 43.5 | 0.0 | 9.5 | 1.5 | 2.0 | 41.0 | 41.0 |
|